 GAITHERSBURG, Md. and HOLZGERLINGEN, Germany, Oct. 28, 2020 GLOBE NEWSWIRE -- OpGen, Inc. Nasdaq: OPGN, OpGen, a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today the award of a German Federal Government grant to its subsidiary, Curetis GmbH, and collaborators Carpegen GmbH Muenster, Germany and the Clinic for Small Animal Internal Medicine of the LMU Ludwig-Maximilians- University Munich, Germany. 